Cibus CEO foretells gene editing and bioinformatics to target peanut allergens

December 09, 2019 | Case Study

Crop and livestock trait development with gene editing (GE) is on the mind of every business across the agriculture industry. Peter Beetham (CEO of Cibus) provided a recent and optimistic opinion in Scientific American. Cibus (Lux Take: Positive) is a well-funded GE trait developer employing gene repair oligonucleotides (GRON) to improve the precision of tools like TALEN and CRISPR/Cas by avoiding the associated repair errors. Cibus holds patents for the technology and is among the few developers with a commercialized gene-edited trait: sulfonylurea resistance in canola. Peter shared a view of overcoming human health issues associated with food through the confluence of GE and bioinformatics for crop development, starting with peanuts.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978